Zebrafish behavioral response to ivermectin: Insights into potential neurological risk

Simple item page
dc.contributor.authorPowrie, Yigael
dc.contributor.authorStrydom, Morné
dc.contributor.authorAucamp, Marique
dc.date.accessioned2022-08-30T08:29:53Z
dc.date.available2022-08-30T08:29:53Z
dc.date.issued2022
dc.description.abstractIvermectin is a well‐known and widely used anti‐parasitic drug. Recently, in vitro data suggest anti‐viral effi- cacy of the drug, albeit at much higher concentrations than currently approved. Despite warnings by several governing bodies, the (uncontrolled) human use of ivermectin has significantly increased during the COVID‐ 19 epidemic. This study thus aimed to elucidate potential neurological risk of particularly the veterinary for- mulation of ivermectin in comparison to pure ivermectin. Zebrafish eggs (1hpf) and larvae (4dpf) were exposed to a range of concentrations of either pure ivermectin (IVM) or a veterinary formulation (V‐IVM) for a period of 24 hours. Behavioral responses to both treatments were assessed at various timepoints using the pentylenete- trazol assay, the light–dark assay and a 5‐day teratogenesis protocol. In addition, dissolution rates were calcu- lated for both treatments.en_US
dc.identifier.citationPowrie, Y. et al. (2022). Zebrafish behavioral response to ivermectin: Insights into potential neurological risk. Medicine in Drug Discovery, 16, 100141. https://doi.org/10.1016/j.medidd.2022.100141en_US
dc.identifier.issn2590-0986
dc.identifier.urihttps://doi.org/10.1016/j.medidd.2022.100141
dc.identifier.urihttp://hdl.handle.net/10566/7777
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectCovid-19en_US
dc.subjectVeterinary formulationen_US
dc.subjectNeurological risken_US
dc.subjectSARS‐CoV‐2en_US
dc.subjectZebrafishen_US
dc.titleZebrafish behavioral response to ivermectin: Insights into potential neurological risken_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
powrie_zebrafish behavioral response_2022.pdf
Size:
897.42 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (School of Pharmacy)